Re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD Trial.

Suppr

超能文献

作者信息

Shinde Ashwin, Li Richard, Amini Arya, Glaser Scott

机构信息

Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, USA.

出版信息

Eur Urol. 2019 Mar;75(3):e69-e70. doi: 10.1016/j.eururo.2018.11.008. Epub 2018 Nov 18.

DOI:10.1016/j.eururo.2018.11.008

PMID:30463663

Abstract

摘要

相似文献

Eur Urol. 2019 Mar;75(3):e69-e70. doi: 10.1016/j.eururo.2018.11.008. Epub 2018 Nov 18.

Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8: Future Steps for Definitive Therapy in Metastatic Prostate Cancer: Lessons from the HORRAD TrialUntil Randomised Controlled Trials Prove Different, Treat the Patient, Not His Imaging Results.回复阿什温·辛德、理查德·李、阿莉亚·阿米尼和斯科特·格拉泽给编辑的信，信的内容涉及：利塞尔洛特·M·S·博埃夫、马腾·C·C·M·胡尔肖夫、安德烈·N·维斯等人。在一项前瞻性随机临床试验中，单纯雄激素剥夺疗法与雄激素剥夺疗法联合前列腺同步放射疗法对原发性骨转移性前列腺癌患者生存的影响：来自HORRAD试验的数据。《欧洲泌尿外科杂志》2019年；75卷：410 - 418页：转移性前列腺癌确定性治疗的未来步骤：来自HORRAD试验的经验教训直到随机对照试验证明情况不同之前，治疗患者，而非其影像学结果。

Eur Urol. 2019 Mar;75(3):e71-e72. doi: 10.1016/j.eururo.2018.11.007. Epub 2018 Nov 22.

Re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.回复：利塞尔otte M.S. 博埃夫、马尔滕 C.C.M. 胡尔绍夫、安德烈 N. 维斯等。前瞻性随机临床试验中，单纯雄激素剥夺疗法与雄激素剥夺疗法联合同期前列腺放疗对原发性骨转移性前列腺癌患者生存率的影响：HORRAD试验数据。《欧洲泌尿外科杂志》2019年；75卷：410 - 418页。

Eur Urol. 2019 May;75(5):e129-e130. doi: 10.1016/j.eururo.2018.12.025. Epub 2018 Dec 24.

Eur Urol. 2019 Apr;75(4):e100. doi: 10.1016/j.eururo.2018.11.030. Epub 2018 Nov 23.

Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.

Eur Urol. 2019 May;75(5):e131-e132. doi: 10.1016/j.eururo.2018.12.024. Epub 2019 Jan 4.

Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410-8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?

Eur Urol. 2019 Apr;75(4):e101-e102. doi: 10.1016/j.eururo.2018.11.034. Epub 2018 Nov 30.

Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.回复：利亚姆·伯克、斯蒂芬·吉尔伯特、理查德·胡珀等人。生活方式改变对接受晚期前列腺癌长期雄激素剥夺治疗的久坐男性特定疾病生活质量的改善作用：一项随机对照试验。《欧洲泌尿外科杂志》2014年；65：865 - 872；回复：丹尼尔·A·加尔瓦奥、奈杰尔·斯普里、詹姆斯·德纳姆等人。一项针对接受过雄激素抑制和放疗的前列腺癌男性进行的为期一年的多中心随机对照试验，该试验以运动训练改善身体机能为目标（来自TROG 03.04 RADAR研究）。《欧洲泌尿外科杂志》2014年；65：856 - 864；回复：南希·L·基廷、刘庞祥、A·詹姆斯·奥马利、斯蒂芬·J·弗里德兰、马修·R·史密斯。前列腺癌男性糖尿病患者中的雄激素剥夺治疗与血糖控制。《欧洲泌尿外科杂志》2014年；65：816 - 824；回复：克里斯蒂娜·G·耶斯佩森、梅特·诺尔加德、迈克尔·博勒。前列腺癌治疗中的雄激素剥夺治疗与心肌梗死和中风风险：一项基于丹麦全国人口的队列研究。《欧洲泌尿外科杂志》2014年；65：704 - 709。

Eur Urol. 2014 Sep;66(3):e51-2. doi: 10.1016/j.eururo.2014.04.018. Epub 2014 May 10.

Re: Abdenour Nabid, Nathalie Carrier, André-Guy Martin, et al. Duration of Androgen Deprivation Therapy in High-risk Prostate Cancer: A Randomized Phase III Trial. Eur Urol 2018;74:432-31.

Eur Urol. 2019 Mar;75(3):e61-e62. doi: 10.1016/j.eururo.2018.10.030. Epub 2018 Oct 26.

Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.

Eur Urol. 2009 Feb;55(2):e40-2; author reply e45-6. doi: 10.1016/j.eururo.2008.08.039. Epub 2008 Aug 24.

Commentary on "Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial." Gravis G, Fizazi K, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Medical Oncology and Biostatistics, Institut Paoli-Calmettes, Marseille, France. Lancet Oncol 2013;14(2):149-58 [Epub 2013 Jan 8].关于“去势治疗单独或联合多西他赛治疗非去势转移性前列腺癌（GETUG-AFU 15）：一项随机、开放标签、3 期临床试验”的述评。Gravis G、Fizazi K、Joly F、Oudard S、Priou F、Esterni B、Latorzeff I、Delva R、Krakowski I、Laguerre B、Rolland F、Théodore C、Deplanque G、Ferrero JM、Pouessel D、Mourey L、Beuzeboc P、Zanetta S、Habibian M、Berdah JF、Dauba J、Baciuchka M、Platini C、Linassier C、Labourey JL、Machiels JP、El Kouri C、Ravaud A、Suc E、Eymard JC、Hasbini A、Bousquet G、Soulie M、马赛帕利-卡尔梅特研究所肿瘤内科和生物统计学，法国。柳叶刀肿瘤学 2013;14(2):149-58 [Epub 2013 年 1 月 8 日]。

Urol Oncol. 2013 Nov;31(8):1845. doi: 10.1016/j.urolonc.2013.08.011.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验